Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Mar 2022 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| Punjab National Bank PNB | 11 52.4% of comparable | +1.19 Cr | 11 | 4 | 21 |
| Adani Enterprises Limited ADANIENT | 11 47.8% of comparable | +0.02 Cr | 11 | 4 | 23 |
| Balkrishna Industries Limited BALKRISIND | 11 32.4% of comparable | +66,956 | 11 | 5 | 34 |
| Piramal Enterprises Limited | 11 35.5% of comparable | -29,178 | 11 | 6 | 31 |
| Zydus Lifesciences Limited ZYDUSLIFE | 11 37.9% of comparable | -0.02 Cr | 11 | 7 | 29 |
| DLF Limited DLF | 11 32.4% of comparable | -0.23 Cr | 11 | 8 | 34 |
| PVR INOX Limited PVRINOX | 11 28.9% of comparable | -0.04 Cr | 11 | 12 | 38 |
| Bosch Limited BOSCHLTD | 10 38.5% of comparable | -10,845 | 10 | 2 | 26 |
| Colgate Palmolive (India) Limited COLPAL | 10 47.6% of comparable | +15,412 | 10 | 3 | 21 |
| Pidilite Industries Limited PIDILITIND | 10 41.7% of comparable | -0.01 Cr | 10 | 4 | 24 |
| The Ramco Cements Limited RAMCOCEM | 10 27.8% of comparable | -0.17 Cr | 10 | 4 | 36 |
| Aurobindo Pharma Limited AUROPHARMA | 10 29.4% of comparable | -0.04 Cr | 10 | 4 | 34 |
| Torrent Pharmaceuticals Limited TORNTPHARM | 10 33.3% of comparable | +0.01 Cr | 10 | 4 | 30 |
| Laurus Labs Limited LAURUSLABS | 10 24.4% of comparable | +0.14 Cr | 10 | 4 | 41 |
| NMDC Limited NMDC | 10 34.5% of comparable | -0.16 Cr | 10 | 6 | 29 |
| Zee Entertainment Enterprises Limited ZEEL | 10 32.3% of comparable | -0.35 Cr | 10 | 9 | 31 |
| 3M India Limited 3MINDIA | 9 33.3% of comparable | -5,551 | 9 | 1 | 27 |
| Fortis Healthcare Limited FORTIS | 9 25.7% of comparable | +0.25 Cr | 9 | 2 | 35 |
| Indus Towers Limited INDUSTOWER | 9 45.0% of comparable | +0.20 Cr | 9 | 2 | 20 |
| HDFC Asset Management Company Limited HDFCAMC | 9 30.0% of comparable | -92,962 | 9 | 3 | 30 |
| Alkem Laboratories Limited ALKEM | 9 22.5% of comparable | +0.03 Cr | 9 | 3 | 40 |
| JK Cement Limited JKCEMENT | 9 20.5% of comparable | -0.03 Cr | 9 | 3 | 44 |
| J.B. Chemicals & Pharmaceuticals Lt JBCHEPHARM | 9 21.4% of comparable | +0.04 Cr | 9 | 4 | 42 |
| Page Industries Limited PAGEIND | 9 22.5% of comparable | -4,600 | 9 | 4 | 40 |
| Siemens Limited SIEMENS | 9 25.7% of comparable | -0.03 Cr | 9 | 6 | 35 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →